Synthesis, -adrenoceptor pharmacology and toxicology of S-(-)-1-(4-(2-ethoxyethoxy)phenoxy)-2-hydroxy-3-(2-(3,4-dimethoxyphenyl)ethy lamino)propane hydrochloride, a short acting 1 -specific antagonist

Author： Jackman G.P.   Iakovidis D.   Nero T.L.   Anavekar N.S.   Rezmann-Vitti L.A.   Louis S.N.S.   Mori M.   Drummer O.H.   Louis W.J.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.37, Iss.9, 2002-09, pp. : 731-741

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Facilitation of cognitive functions by a specific 2 -adrenoceptor antagonist, atipamezole

By Haapalinna A.   Sirvio J.   Lammintausta R.  

European Journal of Pharmacology, Vol. 347, Iss. 1, 1998-04 ,pp. : 29-40

Elsevier

Access to resources Recommend Favorite

Effect of short- and long-acting 2 -adrenoceptor agonists on pulmonary 2 -adrenoceptor expression in human lung

By Nishikawa M.   Mak J.C.W.   Barnes P.J.  

European Journal of Pharmacology, Vol. 318, Iss. 1, 1996-12 ,pp. : 123-129

Elsevier

Access to resources Recommend Favorite

Anti-inflammatory effects of a short-acting and a long-acting 2 -adrenoceptor agonist in guinea pig skin

By Teixeira M.M.   Williams T.J.   Hellewell P.G.  

European Journal of Pharmacology, Vol. 272, Iss. 2, 1995-01 ,pp. : 185-193

Elsevier

Access to resources Recommend Favorite

In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK 1 and NK 2 receptor antagonist

By Robineau P.   Lonchampt M.   Kucharczyk N.   Krause J.E.   Regoli D.   Fauchere J.-L.   Prost J.-F.   Canet E.  

European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. : 677-684

Elsevier

Access to resources Recommend Favorite

1 - and 2 -Adrenoceptor antagonist activity of a series of para-substituted N-isopropylphenoxypropanolamines

By Louis S.N.   Nero T.L.   Iakovidis D.   Colagrande F.M.   Jackman G.P.   Louis W.J.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 11, 1999-11 ,pp. : 919-937

Elsevier

Access to resources Recommend Favorite